Better information makes for healthier horses,
Horseadvice.com is where equine science and horse sense intersect.

Discussion on Research Summary: Nimesulide use in the horse

Use the navigation bar above to access articles and more discussions on this topic.
Author Message
Top of pagePrevious messageNext messageBottom of page Link to this message

Robert N. Oglesby DVM
Moderator
Username: dro

Post Number: 18273
Registered: 1-1997
Posted on Wednesday, Apr 18, 2007 - 9:34 am:   Edit PostPrint Post

Equine Vet J. 2007 Mar;39(2):136-42.
Oral and intravenous administration of nimesulide in the horse: rational dosage regimen from pharmacokinetic and pharmacodynamic data.

Villa R, Cagnardi P, Belloli C, Zonca A, Ziz zadoro C, Ferro E, Carli S.

Department of Veterinary Sciences and Technologies for Food Safety, University of Milan, Via Celoria, 10, 20133 Milan, Italy.

REASONS FOR PERFORMING STUDY: The selective COX-2-inhibitor nimesulide is used extra-label in equine veterinary practice as an anti-inflammatory agent. However, there are no data on which to base the rational use of the drug in this species. OBJECTIVES: To determine the effective COX selectivity of nimesulide in the horse, and suggest a suitable dosing schedule. METHODS: The pharmacokinetics of nimesulide in the horse after oral administration (1 mg/kg bwt), and oral and i.v. administration (1.5 mg/kg bwt) were investigated, effects of feeding status on bioavailability determined, and plasma protein binding of the drug and its principal metabolites measured. Compartmental and noncompartmental pharmacokinetic analyses were performed. The plasma concentration-time profile was used, together with in vitro literature data on nimesulide inhibition of COX isoforms, to determine the effective COX selectivity of nimesulide in the horse, and suggest a suitable dosing schedule. RESULTS AND CONCLUSIONS: The findings suggest that 1.5 mg/kg bwt may produce adequate clinical effects, and the dosing interval should be 12-24 h depending on condition severity. However, at that dose, the concentration in the animal exceeds the in vitro IC50 for both isoforms, so that COX-1/COX-2 selectivity is lost and side-effects due to COX-1 inhibition are a possibility. Nimesulide should therefore be used with caution in equine clinical practice.
Post a Message to this Discussion
Posting
Instructions:
Full Service Members may post to this discussion and should address the orignial poster's concerns or other information posted here. New questions about your horse should be started in a new discussion. Use the navigation bar at the top of this page to return to the parent article and review the article and existing discussions. If your question remains unanswered "Start a New Discussion", the link is under the list of discussions at the bottom of the article.
Post:
Bold text Italics Underline Create a hyperlink Insert a clipart image

Username:
Password:
Options: Enable HTML code in message
Automatically activate URLs in message
Action:
Home Page | Todays Discussions | Search | Top of Page Administration
  http://www.horseadvice.com
is The Horseman's Advisor
Helping Thousands of Equestrians, Farriers, and Veterinarians Every Day
All rights reserved, © 2009
BBB Reliability Seal